Favom, the pioneers in healthcare AI and machine learning, have been confirmed as the headline sponsor for Digital Health’s new show, Digital Health AI and Data 2023.Favom is the marriage of some of the…
Continue Reading
“AI may be on its way to your doctor’s office, but it’s not ready to see patients,” a Los Angeles Times article proclaimed this spring. It’s not the first to remind us: For all…
Continue Reading
While AI adoption is increasing in healthcare, there are privacy and content risks that come with technology advancements.Healthcare organizations, according to Dr. Terri Shieh-Newton, an immunologist and a member at global law firm Mintz,…
Continue Reading
Lyric Announces New AIaaS Offering and Investment from Rory Mcllroy’s Symphony Ventures
Lyric, an industry leader in payment accuracy, today unveiled its groundbreaking Artificial Intelligence as a Service (AIaaS) solution, LyriclQ. Backed by Lyric’s three…
Background: Personal sensing may improve digital therapeutics for mental health care by facilitating early screening, symptom monitoring, risk prediction, and personalized adaptive interventions. However, further development and the use of personal sensing requires a…
Continue Reading
By Shania Kennedy
August 28, 2023 – A machine learning (ML) model can automatically predict esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA) three years before a formal diagnosis, according to a study published recently in…
Continue Reading
By Shania Kennedy
August 18, 2023 – In a study recently published in JAMA Network Open, researchers have externally validated a machine learning (ML) model designed to predict six-month mortality risk for patients with advanced cancer…
Continue Reading
Images depicting dark skin tones are significantly underrepresented in the educational materials used to teach primary care physicians and dermatologists to recognize skin diseases. This could contribute to disparities in skin disease diagnosis across…
Continue Reading
Viz.ai gains FDA De Novo approval for its AI-driven algorithm detecting hypertrophic cardiomyopathy (HCM). This breakthrough software evaluates electrocardiograms, alerting specialists to suspicious findings for further assessment. The FDA’s recognition establishes a new category…
Continue Reading
The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its…
